---
# 
author: "John Slough"
format:
  revealjs:
    self-contained: true
    theme: [night]
    slide-number: true
    
---

<div style="font-size: 200%; margin-top: 1.5em; text-align: center; font-weight: bold;">
Kombucha
</div>

<div style="margin-top: 1.2em; margin-bottom: 1.5em; text-align: center; font-weight: bold; font-size: 120%;">
Health Effects from Human Trials
</div>

<hr style="width: 45%; margin: 2em auto 2em auto; border: 0.5px solid #888;">

<div style="text-align: center; font-size: 90%;">
John Slough  
<em>This is not medical advice</em>  
</div>


---

## Overall Findings {.smaller}

- **Human RCTs** are growing, but still limited
  - mostly from small / pilot trials
- **Animal and mechanistic data** dominate much of the literature

::: {.fragment}

#### Potential Benefits (tentative):
<ul style="margin-top:0; line-height:1.2; font-size:80%; padding-left:1.5em;">
  <li>Glycemic control</li>
  <li>Gut health, symptom relief</li>
  <li>Anti-inflammatory & anti-oxidant activity</li>
  <li>Possible liver support (in animals)</li>
</ul>

:::

::: {.fragment}

- **Adverse effects**: mostly mild GI symptoms
- **Warnings**: mainly with homebrewed or high-volume use

:::

---

## Sugar Amount {.smaller}

- 1 - 24 grams per 100 mL [(commercial)](https://www.mdpi.com/2306-5710/6/1/15)
- similar for home brew
- depends on fermentation length

for a typical 100 g/L sugar starter:

After 7 days → ~34 g/L remaining

After 21 days → ~19 g/L remaining

# Glycemic Control


## Glycemic Control {.smaller}

[Kombucha tea as an anti-hyperglycemic agent in humans with diabetes - a randomized controlled pilot investigation (2023)](https://pubmed.ncbi.nlm.nih.gov/37588049/)

> "Kombucha lowered average fasting blood glucose levels at 4 weeks compared to baseline (164 vs. 116 mg/dL, p = 0.035), whereas the placebo did not (162 vs. 141 mg/dL, p = 0.078)."

- possibly positive for blood sugar levels but small sample size

---

## Glycemic Control {.smaller}

[Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study (2024)](https://pubmed.ncbi.nlm.nih.gov/39738315/)

> "paired analysis between baseline and end of intervention time points within kombucha or control groups revealed **increases in fasting insulin** and in HOMA-IR in the kombucha group"

- Generally not a good thing for blood sugar management
- unclear how much sugar in the kombucha: "16 oz of a commercial kombucha beverage"
- small study, only 24 participants

---

## Glycemic Control {.smaller}

[Glycemic index and insulin index after a standard carbohydrate meal consumed with live kombucha: A randomised, placebo-controlled, crossover trial](https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2023.1036717/full)

2023 Study, 11 participants, on post-prandial glucose response of kombucha compared to 2 other drinks

- 330 ml of Schweppes soda water (placebo) 
- diet lemonade soft drink (Schweppes Zero Sugar) 
- organic kombucha (The Good Brew Company Pty Ltd., VIC, Australia)

The Kombucha added 3g of carbohydrate (1.7g sugar) to the test meal 

Soda water and diet lemonade did not contain any sugar.


---


## Glycemic Control {.smaller}

::: columns

::: {.column width="50%"}

- Kombucha with a meal led to a more moderate rise in blood glucose between 30–60 minutes  
  - at 30 min: **Kombucha: 36 mg/dL**, **Lemonade: 56 mg/dL**, **Soda: 65 mg/dL**
  
- Peak glucose rise was significantly lower vs. soda water and diet lemonade (p = 0.003, p = 0.008)

:::

::: {.column width="50%"}

<a href="https://www.frontiersin.org/files/Articles/1036717/fnut-10-1036717-HTML-r1/image_m/fnut-10-1036717-g001.jpg" target="_blank">
  <img src="assets/glucose-curve.jpg" width="100%" style="display: block; margin: auto;" />
</a>

:::

:::

::: {.fragment}

**Conclusion:** A standard serving of kombucha, consumed with a high-GI, rice-based meal:

  - produced "clinically significant reductions in postprandial glycemia and insulinemia"
  - Effect observed in **healthy adults**

:::


# Gut Health


## Gut Health {.smaller}

[2024 RCT: Kombucha and the Gut Microbiome](https://www.nature.com/articles/s41598-024-80281-w#MOESM1)  
8-week trial in 30 healthy adults

- No change in overall diversity, but specific species shifted

- **Probiotic increases:**  
  <ul style="margin-top:0; margin-bottom:0; font-size:80%; line-height:1.2; padding-left:1.5em;">
    <li><i>Weizmannia coagulans</i> — probiotic added to kombucha</li>
    <li>SCFA producers (e.g. <i>Prevotella</i>, <i>Bifidobacterium</i>) → may support gut lining and reduce inflammation</li>
    <li><i>Ellagibacter</i> — helps break down dietary polyphenols</li>
  </ul>

- **Probiotic decreases:**  
  <ul style="margin-top:0; margin-bottom:0; font-size:80%; line-height:1.2; padding-left:1.5em;">
    <li>↓ <i>Fusobacterium</i>, <i>Parabacteroides</i> — possibly favorable</li>
    <li>↓ <i>Lactobacillus</i> — often beneficial; unclear impact here</li>
  </ul>

- No effect on blood biomarkers or inflammation

- Suggests **short-term microbial reshaping** from probiotics + fiber;  
  clinical impact unclear without longer trials
  
## Gut Health {.smaller}

[The Impact of Green Tea Kombucha on the Intestinal Health, Gut Microbiota, and Serum Metabolome of Individuals with Excess Body Weight in a Weight Loss Intervention: A Randomized Controlled Trial](https://www.mdpi.com/2304-8158/13/22/3635)

10 week study on 59 participants from 2024

#### GI symptom improvements (vs. control)
<ul style="margin-top:0; font-size:75%; line-height:1.2; padding-left:1.5em;">
  <li>Reduced hard stools (<i>p</i> = 0.001)</li>
  <li>Improved sensation of not completely emptying the intestine (<i>p</i> = 0.027; Δ <i>p</i> = 0.002)</li>
  <li>Less "having a stomach full of air" (<i>p</i> = 0.046)</li>
  <li>Reduced reflux (<i>p</i> = 0.043)</li>
  <li>Lower total GSRS symptom score (<i>p</i> = 0.035) (Gastrointestinal Symptom Rating Scale)</li>
</ul>

#### Gut Barrier-related outcomes
<ul style="margin-top:0; font-size:75%; line-height:1.2; padding-left:1.5em;">
  <li>Intestinal permeability and fecal pH worsened in controls only</li>
  <li>Suggests kombucha may help maintain gut barrier and pH balance</li>
</ul>

::: {.fragment}

<div style="font-size: 85%;">

Note: Only "not completely emptying the intestine" showed a statistically significant difference in change (Δ) between groups (<i>p</i> = 0.002); other <i>p</i>-values reflect final score comparisons.

</div>

:::

---


<a href="https://www.mdpi.com/2304-8158/13/22/3635" target="_blank">
  <img src="assets/bowels1.png" width="100%" style="display: block; margin: auto;" />
</a>

---

<a href="https://www.mdpi.com/2304-8158/13/22/3635" target="_blank">
  <img src="assets/bowels2.png" width="100%" style="display: block; margin: auto;" />
</a>

---

## Gut Health {.smaller}

#### Constipation-Predominant IBS (irritable bowel syndrome)

[10-day RCT: Pasteurized Kombucha + Inulin vs. Water](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10750126/)  
<ul style="margin-top: 0; margin-bottom: 0; font-size: 80%; line-height: 1.2; padding-left: 1.5em;">
  <li>40 women with IBS-C</li>
  <li>Increased stool frequency (0.60 → 0.85/day, <i>p</i> = 0.004)</li>
  <li>Stool consistency improved</li>
  <li>Reduced incomplete evacuation; no adverse effects</li>
  <li>Inulin may explain at least part of the benefit</li>
</ul>

<br>

#### Inflammatory Bowel Disease (Crohn’s, UC)
<ul style="margin-top: 0; margin-bottom: 0; font-size: 80%; line-height: 1.2; padding-left: 1.5em;">
  <li>No human trials; only anecdotal symptom reports</li>
  <li>Mouse study: kombucha polysaccharide reduced colitis severity, improved gut barrier integrity</li>
  <li>Live cultures may pose risk, caution advised in IBD</li>
</ul>

---

## Gut Health {.smaller}

- The study on [green tea kombucha](https://www.mdpi.com/2072-6643/16/18/3186) states:  
  *"Kombucha has been associated with decreasing gastrointestinal symptoms in individuals with inflammatory bowel disease [17]."*

- But reference [17] is a [pilot RCT in women with IBS-C](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10750126/) — it does **not mention IBD** or its subtypes (Crohn’s, ulcerative colitis)


- A Google Scholar search for "kombucha inflammatory bowel disease" ranks the IBS study among the top results

<ul style="margin:0 0 0 0; line-height:1.1; font-size:80%; padding-left: 2.3em;">
  <li><b>IBS:</b> Discomfort without long-term damage (pain, bloating, irregularity)</li>
  <li><b>IBD:</b> Chronic inflammation with risk of bleeding, hospitalization, complications</li>
</ul>

<br>

::: {.fragment}

#### Citation Cascade / Citation Distortion

[How citation distortions create unfounded authority: analysis of a citation network](https://www.bmj.com/content/339/bmj.b2680)

:::

# Anti-inflammatory Effects

## Anti-inflammatory Effects {.smaller}

[Green Tea Kombucha Impacts Inflammation and Salivary Microbiota in Individuals with Excess Body Weight: A Randomized Controlled Trial](https://www.mdpi.com/2072-6643/16/18/3186)

::: columns

::: {.column width="60%"}

- Kombucha didn’t boost weight loss or most inflammation markers but it did:
  - **blunt IL-6 increase** vs. control (IL-6 increased in both groups)
  - unclear if this blunting is clinically significant (it is statistically)
  - reduce lipid accumulation product (LAP) (p = 0.029)

    - **LAP:** Index for estimating metabolic risk (CVD, type 2 diabetes)

:::

::: {.column width="40%"}

<br>

<a href="https://www.mdpi.com/2072-6643/16/18/3186" target="_blank">
  <img src="assets/il6.png" width="100%" style="display: block; margin: auto;" />
</a>

::: 

:::



# Anti-oxidant Effects

## Anti-oxidant Effects {.smaller}

**Human Evidence:**

- No human randomized controlled trials have directly measured anti-oxidant biomarkers  

- Reviews emphasize a lack of direct anti-oxidant outcome trials in humans  
  - [Olowoake et al., 2023](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530084/)
  
---

## Anti-oxidant Effects {.smaller}

**Animal & in vitro evidence:**

- [Kombucha reduces oxidative stress in hepatocytes and rodent tissues](https://pubmed.ncbi.nlm.nih.gov/21388793/)  
  - lower lipid peroxidation (MDA), ↑ Anti-oxidant enzymes (SOD, catalase, GSH) in liver and kidney cells  
  - More potent than black tea in models of toxicant exposure  

- [Kombucha’s fermentation enhances Anti-oxidant capacity](https://www.frontiersin.org/articles/10.3389/fmicb.2023.1254014/full)
  - Increases total phenolic content and free-radical scavenging (DPPH, hydroxyl, superoxide assays)  
  - Stronger Anti-oxidant activity than unfermented tea  


::: {.fragment}

- Conclusion: Kombucha shows robust anti-oxidant effects in cell and animal models, but **these effects remain untested in humans**

:::

# Liver Function


## Liver Function & Kombucha {.smaller}

- **No human trials** yet on kombucha in liver disease, NAFLD, or elevated liver enzymes  
- **Animal models** show strong hepatoprotective effects in metabolic and toxic injury contexts

<ul style="margin-top:0; margin-bottom:0; font-size:80%; line-height:1.2; padding-left:1.5em;">
  <li>[Toxin-induced injury (rats)](https://pubmed.ncbi.nlm.nih.gov/19420997/): kombucha-fermented black tea lowered ALT, AST, ALP, MDA; protected against necrosis, better than black tea.</li>
  <li>[Fatty liver (NAFLD) models](https://pubmed.ncbi.nlm.nih.gov/34617537/): reduced hepatic steatosis and inflammation in high-fat/fructose-fed rats</li>
  <li>[Diabetic models](https://pubmed.ncbi.nlm.nih.gov/23907022/): improved liver and kidney function in diabetic rats</li>
</ul>

::: {.fragment}

Strong preclinical data support kombucha as a liver-support candidate, but **no direct human evidence** yet.

:::


# Adverse Effects & Warnings

## Adverse Effects & Warnings {.smaller}

- **Mild GI symptoms** common in trials (e.g. bloating, diarrhea) 
  ([Ecklu-Mensah et al., 2024](https://www.nature.com/articles/s41598-024-80281-w))

- **Serious liver injury** reported:  
  <ul style="margin:0; line-height:1; font-size:80%; padding-left:1.5em;">
    <li>Case of acute cholestatic hepatitis after ~1 month of kombucha use  
    in a woman with diabetes and hypothyroidism; resolved with treatment</li>  
    <li>([Gedela et al., 2023, *Heliyon*](https://www.researchgate.net/publication/296671257_A_Case_of_Hepatotoxicity_Related_to_Kombucha_Tea_Consumption))</li>
  </ul>

- **Iowa CDC case (1995):**  
  <ul style="margin:0; line-height:1; font-size:80%; padding-left:1.5em;">
    <li>Two women hospitalized after drinking homemade kombucha for 2 months;  
    one died from severe metabolic acidosis</li>
    <li>"Possibly Associated with Consumption of Kombucha Tea"</li>
    ([CDC MMWR, 1995](https://www.cdc.gov/mmwr/preview/mmwrhtml/00039742.htm))</li>
  </ul>

**Caution:** Most serious harms involved **improperly prepared homemade** or **excessive daily use**.  
  When brewed safely and consumed in moderation, kombucha appears well-tolerated by most.
  
  
# Conclusion

## Kombucha Health Effects {.smaller}

::: {.fragment}

- **Some potential benefits shown in small human trials**:
  <ul style="margin:0 0 0.8em 0; font-size:80%; line-height:1.3; padding-left:1.5em;">
    <li>↓ Post-meal blood sugar spikes (esp. with high-GI meals)</li>
    <li>↓ Gastrointestinal symptoms in some settings (e.g. constipation, bloating)</li>
    <li>↑ Favorable shifts in gut microbiota (short-term, unclear of clincial relevance)</li>
    <li>Blunted inflammatory marker (IL-6) in one study</li>
  </ul>

:::

::: {.fragment}

- **No clinical evidence yet** for:
  <ul style="margin:0 0 0.8em 0; font-size:80%; line-height:1.3; padding-left:1.5em;">
    <li>Antioxidant effects in humans</li>
    <li>Liver support (only animal data so far)</li>
  </ul>

:::

::: {.fragment}

- **Safety profile appears decent**, but:
  <ul style="margin:0; font-size:80%; line-height:1.3; padding-left:1.5em;">
    <li>GI discomfort (bloating, diarrhea) is common</li>
    <li>Rare serious harms linked to homebrewed or high-volume use</li>
  </ul>

:::

::: {.fragment}

<div style="font-size:85%; margin-top:0.8em;">
Kombucha appears <i>possibly helpful</i> for digestion and glycemic response in some people,<br>
but larger human trials are needed to draw confident health conclusions.
</div>

:::